Marwah Harneet, Garg Tarun, Goyal Amit K, Rath Goutam
a Department of Pharmaceutics , ISF College of Pharmacy , Moga , Punjab , India.
Drug Deliv. 2016;23(2):564-78. doi: 10.3109/10717544.2014.935532. Epub 2014 Jul 9.
Today, ∼74% of drugs are taken orally and are not found to be as effective as desired. To improve such characteristics, transdermal drug delivery was brought to existence. This delivery system is capable of transporting the drug or macromolecules painlessly through skin into the blood circulation at fixed rate. Topical administration of therapeutic agents offers many advantages over conventional oral and invasive techniques of drug delivery. Several important advantages of transdermal drug delivery are prevention from hepatic first pass metabolism, enhancement of therapeutic efficiency and maintenance of steady plasma level of the drug. Human skin surface, as a site of drug application for both local and systemic effects, is the most eligible candidate available. New controlled transdermal drug delivery systems (TDDS) technologies (electrically-based, structure-based and velocity-based) have been developed and commercialized for the transdermal delivery of troublesome drugs. This review article covers most of the new active transport technologies involved in enhancing the transdermal permeation via effective drug delivery system.
如今,约74%的药物通过口服给药,但效果并未达到预期。为改善这些特性,经皮给药应运而生。这种给药系统能够以固定速率将药物或大分子无痛地透过皮肤输送到血液循环中。与传统的口服和侵入性给药技术相比,局部给药具有许多优势。经皮给药的几个重要优势包括避免肝脏首过代谢、提高治疗效果以及维持药物的稳定血浆水平。人体皮肤表面作为局部和全身效应药物应用的部位,是最合适的选择。新型控释经皮给药系统(TDDS)技术(基于电、基于结构和基于速度)已被开发并商业化,用于难处理药物的经皮给药。这篇综述文章涵盖了通过有效给药系统增强经皮渗透所涉及的大多数新型主动转运技术。
Drug Deliv. 2016
Pharmacol Rep. 2018-10-11
J Control Release. 2012-10-10
Ther Deliv. 2010-7
Tidsskr Nor Laegeforen. 2009-3-12
Recent Pat Drug Deliv Formul. 2009-6
Pharm Dev Technol. 2017-6
Ther Deliv. 2013-10
Curr Pharm Des. 2015
J Nanobiotechnology. 2025-8-21
AAPS PharmSciTech. 2025-8-19
Beilstein J Nanotechnol. 2025-8-1
Front Bioeng Biotechnol. 2025-7-16
Chin Herb Med. 2024-5-17
Pharmaceutics. 2025-7-20
Pharmaceutics. 2025-5-21
Front Med (Lausanne). 2025-3-31